Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Jun 24, 2020 11:48am

123 Views

Post# 31185975

RE:RE:RE:RE:RE:RE:The last patient update was September 30, 2019

Tend to agree realty - after a progressive reduction in information over many years an attempt to further restrict shareholders by introducing a few lines every three months as the new normal - a sort of corporate information lockdown - was the last thing we needed. Guess it must benefit someone though.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta